Mérieux Foundation & University of Geneva co-organized event

20th Advanced Course of Vaccinology (ADVAC)

May 13 - 24, 2019 - Les Pensières Center for Global Health, Veyrier-du-Lac (France)

Context

20th anniversary of ADVAC group

This year marks the 20th anniversary of the Advanced Course of Vaccinology (ADVAC), the two-week intensive course for senior decision-makers and scientists in the field of vaccines, organized at Les Pensières Center for Global Health by the University of Geneva and the Mérieux Foundation.

To celebrate this important milestone, four ADVAC alumni were invited as guest speakers to share their vision for the future of vaccinology and discuss how ADVAC has impacted their own careers:

  • Dr. Béhazine Combadière, Director of research, DR1 Inserm, France (ADVAC 2004),
  • Prof. Gagandeep Kang, Executive Director at the Translational Health Science Technology Institute (THSTI), India (ADVAC 2003),
  • Dr. François Meurice, Director of Scientific Affairs and Public Health, GSK, Belgium (ADVAC 2001),
  • Prof. Nikki Turner, Director, Immunisation Advisory Centre, University of Auckland, New Zealand (ADVAC 2001).

This year’s course had over 70 participants from academia, industry, governmental and non-governmental agencies and more than 60 leading specialists as lecturers.

Learn more about ADVAC

Learn more about the 20 years of ADVAC

In 2019, ADVAC celebrates its 20th anniversary!

ADVAC Special Alumni speakers

  • Dr. François MEURICE

    Belgium
    ADVAC 2000

  • Prof. Nikki TURNER

    New Zealand
    ADVAC 2001

  • Dr. Gagandeep KANG

    India
    ADVAC 2003

  • Dr. Béhazine COMBADIÈRE

    France
    ADVAC 2004

ADVAC Special Alumni speakers

  • Dr. François MEURICE

  • Prof. Nikki TURNER

  • Dr. Gagandeep KANG

  • Dr. Béhazine COMBADIÈRE

ADVAC Alumni share their perspectives

2001

Prof Gerardo GUILLÉN

“Prevention is more cost-effective than treat and have higher impact on quality of life.”
Read the interview

2008

Dr Beckie TAGBO

“One main challenge remains - developing Vaccine against the Ebola virus.”
Read the interview

2010

Dr Desiree WITTE

“The effectiveness of Rotavirus vaccine in Malawi has found that the risk of diarrhea has reduced by 64%.”
Read the interview

2010

Dr Cecile van ELS

“We need to accelerate the development and release of safe new and improved vaccines to prevent disease and death caused by many (re-)emerging infectious diseases.”
Read the interview

2011

Dr Julitasari SUNDORO

“All ADVAC alumni will have the opportunity to be consulted as vital resources of vaccine information.”
Read the interview

2015

Dr Esteban ORTIZ-PRADO

“ADVAC was the most amazing course that I have ever attended.”
Read the interview

2015

Dr Aurora STANESCU

“Vaccination saves lives! So, as long as we can do something - let’s do it!”
Read the interview

2015

Dr Mario MELGAR

“Diseases are changing, population is changing. We need vaccinology more than ever to guide us.”
Read the interview

2016

Dr Gurinder BIR SINGH

“Resurgence of VPDs like Diphtheria, Pertussis has become a major challenge along with the development of vaccines against newly emerging diseases like Zika virus.”
Read the interview

2016

Dr Andrew W LEE

“It was so wonderful and eye-opening to talk with vaccine directors from developing countries and to learn what is important to them.”
Read the interview

ADVAC in figures

70+

Participants each year

1142

Participants since 2000

113

Countries represented since 2000

60+

Top-level international lecturers

4

Alumni meetings each year on current vaccinology topics

60+

Lectures and 10 interactive sessions

    • 72

      Average number of participants per year:

Contact

University of Geneva

Send an e-mail

Next

Previous

Revive

Pause